Tom Stargardt : Citation Profile


Are you Tom Stargardt?

Universität Hamburg

9

H index

8

i10 index

188

Citations

RESEARCH PRODUCTION:

26

Articles

5

Papers

RESEARCH ACTIVITY:

   13 years (2004 - 2017). See details.
   Cites by year: 14
   Journals where Tom Stargardt has often published
   Relations with other researchers
   Recent citing documents: 11.    Total self citations: 13 (6.47 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pst545
   Updated: 2022-09-24    RAS profile: 2018-09-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Tom Stargardt.

Is cited by:

Schreyögg, Jonas (16)

Herr, Annika (8)

Suppliet, Moritz (8)

Blankart, Katharina (6)

Ziebarth, Nicolas (5)

Street, Andrew (5)

Eibich, Peter (4)

Vandoros, Sotiris (4)

Miraldo, Marisa (3)

Blankart, Carl (3)

Iversen, Tor (3)

Cites to:

Schreyögg, Jonas (16)

Manning, Willard (5)

Vandoros, Sotiris (5)

Grootendorst, Paul (4)

Costa-Font, Joan (4)

Devlin, Nancy (3)

Magazzini, Laura (3)

Bertrand, Marianne (3)

Rice, Nigel (3)

Blankart, Katharina (3)

Mullahy, John (3)

Main data


Where Tom Stargardt has published?


Journals with more than one article published# docs
The European Journal of Health Economics8
Health Policy6
Applied Health Economics and Health Policy4
PharmacoEconomics2
Health Care Management Science2
Health Economics2

Working Papers Series with more than one paper published# docs
Discussion Papers / Technische Universitt Berlin, School of Economics and Management2
hche Research Papers / University of Hamburg, Hamburg Center for Health Economics (hche)2

Recent works citing Tom Stargardt (2022 and 2021)


YearTitle of citing document
2021A Hard Look at “Soft” Cost?control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany. (2021). Blankart, Katharina ; Avdic, Daniel. In: CINCH Working Paper Series (since 2020). RePEc:ajt:wcinch:74978.

Full description at Econpapers || Download paper

2022The process of estimating the cost of surgery: Providing a practical framework for surgeons. (2022). Tsoulfas, Georgios ; Tzamalis, Argyrios ; Tooulias, Andreas I ; Athanasiadou, Eleni C ; Christou, Chrysanthos D. In: International Journal of Health Planning and Management. RePEc:bla:ijhplm:v:37:y:2022:i:4:p:1926-1940.

Full description at Econpapers || Download paper

2021Regulatory and HTA early dialogues in medical devices. (2021). Blankart, Carl ; Penton, Hannah ; Dams, Florian ; Federici, Carlo ; Iskandar, Rowan ; Shatrov, Kosta ; Zemplenyi, Antal ; Kalo, Zoltan. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:10:p:1322-1329.

Full description at Econpapers || Download paper

2022Promoting innovation while controlling cost: The UKs approach to health technology assessment. (2022). Mossialos, Elias ; Carter, Paul ; McGuire, Alistair ; Taylor, David ; Drummond, Michael ; Anderson, Michael. In: Health Policy. RePEc:eee:hepoli:v:126:y:2022:i:3:p:224-233.

Full description at Econpapers || Download paper

2021Cream skimming by health care providers and inequality in health care access: Evidence from a randomized field experiment. (2021). Wubker, Ansgar ; Werbeck, Anna ; Ziebarth, Nicolas R. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:188:y:2021:i:c:p:1325-1350.

Full description at Econpapers || Download paper

2021Changes in hospital efficiency and size: An integrated propensity score matching with data envelopment analysis. (2021). Cinaroglu, Songul. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:76:y:2021:i:c:s0038012120307977.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Economic evidence with respect to cost-effectiveness of the transitional care model among geriatric patients discharged from hospital to home: a systematic review. (2021). Rimmele, Martina ; Schoffski, Oliver ; Wachter, Carl-Philipp ; Kast, Kristina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:6:d:10.1007_s10198-021-01301-4.

Full description at Econpapers || Download paper

2021Development of a Conceptual Model of Chronic Lymphocytic Leukemia to Better Understand the Patient Experience. (2021). Eyre, Toby A ; Chung, Helena ; Krogh, Calvin ; Blowfield, Matthew ; Eek, Daniel. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:14:y:2021:i:1:d:10.1007_s40271-020-00440-9.

Full description at Econpapers || Download paper

2021Essays in health economics. (2021). Moura, Ana. In: Other publications TiSEM. RePEc:tiu:tiutis:c93abd22-fa4a-42a5-b172-d6ba7012f3cb.

Full description at Econpapers || Download paper

2021Power of machine learning algorithms for predicting dropouts from a German telemonitoring program using standardized claims data. (2021). Spindler, Martin ; Birkner, Benjamin ; Hofer, Florian. In: hche Research Papers. RePEc:zbw:hcherp:202124.

Full description at Econpapers || Download paper

Works by Tom Stargardt:


YearTitleTypeCited
2012A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data In: Health Policy.
[Full Text][Citation analysis]
article5
2013Reforms in the Greek pharmaceutical market during the financial crisis In: Health Policy.
[Full Text][Citation analysis]
article17
2016Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia In: Health Policy.
[Full Text][Citation analysis]
article7
2016Dispensing behaviour of pharmacies in prescription drug markets In: Health Policy.
[Full Text][Citation analysis]
article0
2016Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—A large population-based cohort study In: Health Policy.
[Full Text][Citation analysis]
article3
2007Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany In: Health Policy.
[Full Text][Citation analysis]
article4
2011Effect of Type of Insurance and Income on Waiting Time for Outpatient Care In: Working Papers.
[Full Text][Citation analysis]
paper14
2012Effect of Type of Insurance and Income on Waiting Time for Outpatient Care.(2012) In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14
article
2011Effect of type of insurance and income on waiting time for outpatient care.(2011) In: hche Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 14
paper
2017Preferred supplier contracts in post-patent prescription drug markets In: Health Care Management Science.
[Full Text][Citation analysis]
article8
2006Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries In: Health Care Management Science.
[Full Text][Citation analysis]
article40
2012Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2013The Trade-off Between Costs and Quality of Care in the Treatment of Psychosomatic Patients with Somatoform Pain Disorder In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article3
2014Cost-Utility Analysis Comparing Heavy-Weight and Light-Weight Mesh in Laparoscopic Surgery for Unilateral Inguinal Hernias In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2016Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article1
2010The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article11
2011Reimbursement of pharmaceuticals: reference pricing versus health technology assessment In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article12
2012Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2014Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2016The diffusion of generics after patent expiry in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2017Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2005Defining the “Health Benefit Basket” in nine European countries In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article12
2005Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2011Availability of and Access to Orphan Drugs In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2016Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2011Modelling pharmaceutical price changes in Germany: a function of competition and regulation In: Applied Economics.
[Full Text][Citation analysis]
article9
2011Costs and quality of hospitals in different health care systems: a multi?level approach with propensity score matching In: Health Economics.
[Full Text][Citation analysis]
article11
2014MEASURING THE RELATIONSHIP BETWEEN COSTS AND OUTCOMES: THE EXAMPLE OF ACUTE MYOCARDIAL INFARCTION IN GERMAN HOSPITALS In: Health Economics.
[Full Text][Citation analysis]
article11
2012Measuring the relationship between costs and outcomes: The example of Acute Myocardial Infarction in German hospitals.(2012) In: hche Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 11
paper
2004Bürgerversicherung: Die Wirkung von Kopfprämien auf den Arbeitsmarkt In: Discussion Papers.
[Full Text][Citation analysis]
paper2
2005Defining benefit catalogues and entitlements to health care in Germany: Decision makers, decision criteria and taxonomy of catalogues In: Discussion Papers.
[Full Text][Citation analysis]
paper1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team